abbreviated new drug application

(redirected from ANDA)
Also found in: Acronyms, Encyclopedia, Wikipedia.

Abbreviated New Drug Application

A simplified submission to the US Food & Drug Administration (FDA) requesting authorization to market a new  formulation of an existing drug or an investigational drug similar to an already approved drug, for which both its therapeutic indications and formulation were previously approved by the FDA.

abbreviated new drug application

Pharmacology An application made in the US by a pharmaceutical company requesting authority to market a 'new' drug for which both its therapeutic indications and formulation were previously approved by the FDA in another similar drug. See Me too drug.

ab·bre·vi·a·ted new drug ap·pli·ca·tion

(ă-brē'vē-ā-tĕd nū drŭg ap'li-kā'shŭn)
A request by a pharmaceutical company to market and sell a pharmaceutical that is essentially the same as another, which has already been granted such approval.

abbreviated new drug application



A formal request to the U.S. Food and Drug Administration to approve a generic drug that is a copy of a patented agent already approved for use.
References in periodicals archive ?
Announced yesterday at GLOBALCOMM, ANDA has certified, type approved, shipped and deployed equipment in 12 new countries outside of ANDA's U.
Tracy has been a valued ANDA financial executive and has the confidence of the management team, board of directors, and outside auditors," said Kenmore.
To further extend their international Ethernet footprint, ANDA is completing 10 additional in-country lab certifications for type approval.
This vigilance ensures that whether it's the latest deals, ANDAs, alliances or litigation you can assess the impact of the development in the context of the company, its competitors and the broader market.
The recently filed ANDAs are for the following products:
ANDA Networks is part of the Soapstone Networks Alliance Partner Program (SNAPP[TM]).
Taejoon and Azad are responsible for completion of the Regulatory dossiers and upon ANDA approval, will manufacture and supply the products to Akorn in a blow-fill seal container closure system.
AMEX: AKN) and Strides Arcolab Limited (NSE: STAR, BSE: 532531) today announced that both Companies have agreed to fund, develop, and commercialize an additional 10 ANDA injectable drug products for the Akorn-Strides, LLC Joint Venture.
16 /PRNewswire/ -- ANDA Networks, a leading developer of high-performance multi-service access platforms, has named Robert Simkavitz as Vice President of Business Development and elected Corporate Officer.
ANDA Networks, the leader in carrier-class fiber and copper-based access platforms for wireline networks or wireless backhaul applications, today announced a distribution partnership with TVC Communications.
ANDA Networks' New EtherSLAM(TM) Provides Next-Gen Ethernet Service Line Access Multiplexor for Carrier Class Ethernet Services